Printer Friendly

National Psoriasis Foundation admits 3,000th patient under its collaborative psoriasis registry model.

M2 EQUITYBITES-June 27, 2017-National Psoriasis Foundation admits 3,000th patient under its collaborative psoriasis registry model


National Psoriasis Foundation stated on Monday that Corrona Psoriasis Registry has enrolled its 3,000th psoriasis patient under its collaborative model that integrates the post-approval safety study (PASS) commitments of multiple companies into a single, large-scale registry with multiple drug treatment cohorts.

Since its launch two years ago, the Corrona Psoriasis Registry is a joint collaboration between the National Psoriasis Foundation (NPF) and Corrona LLC, the leading sponsor of registries in autoimmune and immune-mediated diseases.

The Corrona Psoriasis Registry's 3,000th psoriasis patients come from 128 sites across 33 states. The data from the registry has contributed to 18 research posters that have been presented at medical conferences across the country analyzing disease severity, concurrent medical conditions and patient reported outcomes.

This collaborative model offers numerous advantages, including streamlining the workflow for investigators and patients into a single protocol and set of patient questionnaires. The model has been designated to support US FDA post-approval safety commitments for two recently approved IL-17 inhibitor biologics for psoriasis.

According to the company, the Corrona Psoriasis Registry is the largest, independent US registry of psoriasis patients. The registry was launched as a commitment to the psoriasis community to help researchers compare the safety and effectiveness of US FDA-approved psoriasis therapies.

Psoriasis is a chronic, immune-mediated disease that causes raised, red, scaly patches to appear on the skin. It occurs when the immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis is not contagious.

((Comments on this story may be sent to

COPYRIGHT 2017 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Jun 27, 2017
Previous Article:Bank of the Ozarks announces completion of merger with its parent company.
Next Article:Boeing's board authorises dividend of USD1.42 per share for quarter.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters